News Image

Nuvectis Pharma to Present at the H.C. Wainwright BioConnect Investor Conference

Provided By GlobeNewswire

Last update: May 16, 2025

Fort Lee, NJ, May 16, 2025 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology, today announced that Ron Bentsur, Chairman and Chief Executive Officer, will present at the 3rd Annual H.C. Wainwright Global BioConnect Investor Conference.

Read more at globenewswire.com

NUVECTIS PHARMA INC

NASDAQ:NVCT (6/9/2025, 8:00:02 PM)

After market: 8.85 0 (0%)

8.85

0 (0%)



Find more stocks in the Stock Screener

Follow ChartMill for more